Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Whalatane, alias Akanz:
Instead of putting a gun to Gabor’s head
for his opinion you should be gracious
for his enormous contributions to
this board. For you , is it all about
Picking other people’s brain for free?
To no one:
The difference between opinion and feeling:
https://wikidiff.com/opinion/feeling
Great insight. Please use opinion instead of feeling. Thanks
To all those open to learning:
https://www.ncbi.nlm.nih.gov/m/pubmed/26888894/
This article basically proves that remnant cholesterol contributes
all cause mortality in a step wise manner. If Vascepa can statistically decrease it...
True, more males than females do not take prescribed meds.
Also some participants believe the pills they are taking , will
Improve their lipid profile and it does even if it is not Vascepa. This is
The power of the placebo effect...
Details will take time but results may be out
as early as end of July. Amarin is extremely motivated
To get this out due to the consistency of data. There has not been
any surprise in their projections.
What are you waiting for to get a prescription
Of 4 gram of Vascepa? Even though you
may not be obese have you checked your Insulin
resistance numbers? A lot people wrongly believe
That because their hba1c and fasting blood glucose
are normal, everything is fine regarding developing type 2
DM.
Also do you fast once a week?
Any comments about that paper ?
To Kiwi. alias Akanz
More reading for you. Enjoy
https://www.ncbi.nlm.nih.gov/m/pubmed/23926208/
RAF may be but Kiwi is a calculated fellow bent
On always making a penny using someone else gray matter.
It does not need to give SPECTACULAR
Results, just at or above 15 percent rrr.
What a winner you are?
National tv marketing will take care of that. They
Are already spending $15 m on that...
All I am saying final value will be determined by acquisition and not the results.
I am sure the results will be great based on integration
of mechanistic, epidemiological, genetics and clinical trials data studies.
Only the Anchor data is of interest here.
Final Amrn value will be determined by acquisition
and bidding war, not the results.
You are correct Sir. But it is more than that.
True. Concur
Thanks for attaching the paper showing
Vascepa at 4 grams reduce remnant cholesterol
by 25 percent to those on optimized Statin therapy.
Everything is looking good for Reduce-IT clinical trial results.
All the best,
K
Kiwi is very a dishonest fellow. He only looks
To poke holes in Amarin and to date he has not
Answered Gabor’s many questions .
He believes that if he continues with the same behavior the stock
Will go back to $2.66... There is a song by Bees that
Says ... how can a loser ever win....
Sorry I mean accumulating more...
Would you mind sharing on what grounds
the thoracic surgeon convince you to
Buy Amrn?
Thanks
Ps Congrats for acclimating more. This is
about paradigm shift...
Dear Kiwi, alias Akanz:
I am curious to know why Amarin
Rejected you as a participant
In Reduce-IT. Would you mind refreshing our mind?
Thanking you in advance.
Best regards
9. Company is so confident of trial results they
Spent $15 million on national tv ads, promoting Vascepa
So that patients will run to their health care providers
Right after Statin + pure EPA (Vascepa) reduces cardiac death for
Those on optimized statin having residual risk with triglyceride between
150-499!!!
Smart move then. I borrowed from 401k
To purchase more.
6. Covered all base by acquiring intellectual
Property of 98 percent EPE , Epadel
7. Alert all potential suitors that generic can only
Start in August 2029 by settling with Teva for
$2.0 M
8. Let the bids begin as soon results are out.
Why sell your latest buy to pay higher tax as it would
Count as short term? Is it not wiser to sell your first in first?
You write a lot with no facts but lots of speculation or made
Up. JL is right about you...
Thanks for keeping us abreast of the legal aspects.
Can you earn a law degree on the side?
This is how integration of knowledge takes place:
http://circres.ahajournals.org/content/118/4/547.long
Thanks. I concur with you. But please note that Nissen
was not the primary or the last author. He does not have
Controlling authority as a co-author.. The data from 7 clinical trial speaks for itself...
You can borrow from your 401k...
Yes you are correct that FDA badly screwed up. Please
Read Gabor’s interpretation of the results of the Puri paper.
All the best
Here is more Kiwi..
http://atvb.ahajournals.org/content/36/11/2133
Enjoy and good night!
BB, would you mind elaborating? Thanks
Yes Kvenne, what you articulated in your last paragraph is exactly
what Kiwi has been advocating for years now.. Thanks Kvenne.
What about risk factors and history of coronary disease?
Just ignore it … Do you recall Amarin turning you down
as a participant? Why? Also low Hdl is absolutely not critical. I addressed that earlier. Best of luck to you.
Here you go again. You miss the most important
aspect of the study. You know me. I will
not educate you..Before September 30, 2018
We will know the results of Reduce-IT.
Best of luck to you.
http://atvb.ahajournals.org/content/36/11/2220?iss=11
To all skeptics please read above and reach your own
Conclusions ...
Thank you Sir for responding promptly
and precisely.... Be safe.
To Gabor:
Hope all is well. Do you know
How many of the 8175 participants
Have triglyceride at or above 200 mg/dL?
Thanking you in advance.
Best regards as always and be safe.
Thank you. Geting impatient waiting
For the results of the outcome study. Loaded more
At $2.73.
God bless you.
Fortunately science will determine the outcome,
not you.